Bg pattern

OKIDOL 25 mg FILM-COATED TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use OKIDOL 25 mg FILM-COATED TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the Patient.

Okidol25 mgfilm-coated tablets

ketoprofen

Read the package leaflet carefully before starting to take this medication, as it contains important information for you.

Follow the administration instructions for the medication contained in this package leaflet or as indicated by your doctor or pharmacist.

  • Keep this package leaflet, as you may need to read it again.
  • If you need advice or more information, consult your pharmacist.
  • If you experience side effects, consult your doctor or pharmacist, even if they are side effects not listed in this package leaflet. See section 4.
  • You should consult a doctor if your condition worsens or does not improve after 3 days of fever and after 5 days of pain.

Contents of the Package Leaflet

  1. What is Okidol and what is it used for
  2. What you need to know before taking Okidol
  3. How to take Okidol
  4. Possible side effects
  5. Storage of Okidol
  6. Contents of the pack and further information

1. What is Okidol and what is it used for

The active substance of this medication is ketoprofen lysine salt, which belongs to a group of medications called "Non-steroidal anti-inflammatory drugs" (NSAIDs). These medications provide short-term relief by changing the body's response to pain, inflammation, and fever. Ketoprofen lysine salt is a salt of ketoprofen that the body absorbs quickly and completely.

Okidol is indicated in adults 18 years and older, for the symptomatic relief of occasional mild to moderate pain, such as muscle and joint pain, headache, pain associated with throat irritation, toothache, and menstrual pain, as well as in febrile states

You should consult a doctor if your condition worsens or does not improve after 3 days of fever and after 5 days of pain.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before taking Okidol

Do not take Okidol:

  • if you are allergic (hypersensitive) to any of the other components of this medication (listed in section 6)
  • if you have asthma or have a history of allergic reactions (hypersensitivity) to ketoprofen or any other NSAID (e.g., acetylsalicylic acid, ibuprofen)
  • during the third trimester of pregnancy (from week 29 onwards). See section 2 "Pregnancy and lactation".
  • if you have severe heart problems where your heart does not work as well as it should
  • if you suffer from or have a history of intestinal problems, such as:

o active peptic ulcer

o stomach or intestinal ulcers

o intestinal bleeding

o holes in the stomach or gastrointestinal tube (gastrointestinal perforation)

o painful or altered digestion, which may include nausea, vomiting, stomach acid, abdominal distension, and stomach discomfort (chronic dyspepsia)

o stomach lining inflammation (gastritis)

  • If you have a low blood cell count (leukopenia or thrombocytopenia), active bleeding, or a tendency to bleed with blood clot prevention medication (anticoagulants)
  • If you have severe kidney or liver problems.

Warnings and precautions

If you notice signs of skin rash, red and painful skin around body openings (mucous membranes), or allergic reactions after taking Okidol, stop taking this medication and inform your doctor immediately.

If you notice any signs of stomach or intestinal bleeding (e.g., bright red stools, black tarry stools, vomiting blood or dark particles that look like coffee grounds), stop taking this medication and inform your doctor immediately.

If you notice any signs of ulcers or perforation (symptoms may include: severe stomach pain, chills, nausea, vomiting, heartburn) after taking Okidol, stop taking this medication and inform your doctor immediately.

Elderly people may experience more side effects with NSAIDs, especially stomach and intestinal side effects, which can be fatal. If you are an elderly patient, the product should be used with caution.

Side effects can be minimized by taking lower doses for the shortest necessary time to relieve symptoms.

Anti-inflammatory/analgesic medications, such as ketoprofen, may be associated with a small increased risk of heart attack or stroke, especially when used in high doses and for prolonged periods. Do not exceed the recommended dose or treatment duration.

The use of Okidol with other products containing NSAIDs (e.g., ibuprofen, aspirin, celecoxib) should be avoided.

Stop taking this medication if you experience any visual problems, such as blurred vision.

Since Okidol is used to treat symptoms such as fever, it may mask an underlying more serious condition. If your symptoms persist, inform your doctor.

Taking an analgesic to relieve headaches for a long time can worsen them.

Consult your doctor or pharmacist before starting to take Okidol:

  • If you are pregnant, trying to become pregnant, or breastfeeding (see section 2 "Pregnancy and lactation")
  • If you suffer from fluid retention and swelling.
  • If you have high blood pressure, your heart is weakened, you have arterial disease, and/or problems with the blood vessels that supply the brain
  • If you have a condition called phenylketonuria, in which your body cannot break down a substance called phenylalanine
  • If you have liver disease.
  • If you suffer from kidney disease.
  • If you have allergies (e.g., hay fever)
  • If you have chronic obstructive pulmonary disease (COPD)
  • If you have hepatic porphyria (a rare blood disease characterized by altered activity of one of the liver enzymes) because the medication could trigger an attack.
    • If you have an infection; see the "Infections" heading below.

Infections

Okidol may hide the signs of an infection, such as fever and pain. Consequently, Okidol may delay the appropriate treatment of the infection, which may increase the risk of complications. This has been observed in bacterial pneumonia and bacterial skin infections related to chickenpox. If you take this medication while having an infection and the symptoms of the infection persist or worsen, consult a doctor without delay.

Children and adolescents

Okidol should not be administered to children under 18 years of age.

Taking Okidol with other medications

Inform your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication. This includes over-the-counter medications or herbal remedies.

You must inform your doctor or pharmacistif you are taking any of the following medications:

  • Medications to improve blood flow, such as anticoagulants (aspirin, warfarin, heparin, policosanol, dabigatran, or clopidogrel), thrombolytics (reteplase, streptokinase), pentoxifylline, prasugrel, coumarins.
  • certain antibiotics (e.g., quinolones, sulfonamides)
  • medications used after organ transplantation to help prevent rejection (e.g., cyclosporine, tacrolimus)
  • medications used for certain types of mental illness and depression (e.g., lithium, venlafaxine, and selective serotonin reuptake inhibitors (SSRIs))
  • other NSAIDs (e.g., aspirin, ibuprofen) or paracetamol
  • diuretics such as bendroflumethiazide
  • glucocorticosteroids (steroid hormones such as hydrocortisone or prednisolone)
  • antiretroviral medications used to treat HIV infections (e.g., ritonavir, zidovudine)
  • medications to treat high blood pressure (e.g., ramipril, captopril, enalapril, losartan, irbesartan)
  • muscle relaxants such as baclofen
  • medications used to treat heart failure and to control heart rate (e.g., digoxin, digitoxin)
  • medications to treat diabetes (e.g., gliclazide)
  • medications used to treat cancer (e.g., erlotinib, pemetrexed, methotrexate)
  • medications to treat gout (e.g., probenecid)
  • diphenylhydantoin - an antiepileptic medication
  • pentoxifylline: a medication used to treat muscle pain
  • penicillamine: a medication used to treat rheumatoid arthritis

Taking Okidol with alcohol

Alcohol can cause irritation of the throat, stomach, and intestines, so there is a higher risk of bleeding and ulcers, and this risk increases when NSAIDs are taken at the same time.

Pregnancy and lactation

Do not take this medication if you are in the third trimester of pregnancy, as it may harm the fetus or cause problems during delivery. It may cause kidney and heart problems in the fetus. It may affect your or your child's predisposition to suffer from bleeding and delay or prolong delivery longer than expected. Ketoprofen should not be used during the first six months of pregnancy unless the clinical situation of the woman requires treatment with ketoprofen. If during this period or while you plan to become pregnant, you need treatment, the lowest dose should be used for the shortest possible time. If ketoprofen is taken for some days from week 20 of pregnancy onwards, it may cause kidney problems in the fetus, which may lead to a reduction in the volume of amniotic fluid surrounding it (oligohydramnios) or narrowing of the blood vessels (ductus arteriosus) of the fetus's heart. If you need treatment for more than a few days, your doctor will recommend closer monitoring.

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

Driving and using machines

If after taking Okidol you feel drowsy, dizzy, have blurred vision, or have convulsions, do not drive, use machinery, or perform activities that require a high level of alertness (see section 4 "Possible side effects").

Okidol contains aspartame (E951)

This medication contains 0.35 mg of aspartame in each sachet. Aspartame contains a source of phenylalanine, which may be harmful in case of phenylketonuria (PKU), a rare genetic disease in which phenylalanine accumulates because the body is unable to eliminate it properly.

Okidol contains glucose and sucrose

If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.

3. How to take Okidol

Follow the administration instructions for this medication as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.

The effective lowest dose should be used for the shortest necessary time to relieve symptoms. If you have an infection, consult a doctor without delay if the symptoms (such as fever and pain) persist or worsen (see section 2).

The recommended dose is 1 sachet up to 3 times a day, as needed.

Wait at least 4 hours before taking another sachet.

Do not exceed the recommended dose.

If the symptoms persist or the pain worsens, or if new symptoms appear, consult your doctor or pharmacist.

Use in children

Okidol should not be taken by children under 18 years of age.

Use in elderly patients

Do not take more than 1 Okidol sachet in 24 hours.

Method of administration

Okidol is for oral use.

The contents of the sachet can be placed directly on the tongue. You can take Okidol with or without water, as the granules will dissolve in your saliva.

If you take more Okidol than you should

If you accidentally take more Okidol than recommended, you may feel drowsy or nauseous. You should seek medical attention immediately, even if you feel well.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service. Telephone 91 562 04 20, indicating the medication and the amount ingested.

If you forget to take Okidol

Do not take a double dose to make up for forgotten doses.

If you forget to take Okidol, take it as soon as possible. Do not take a double dose to make up for the forgotten dose, and make sure to leave a minimum of 4 hours between doses and do not exceed the maximum of 3 tablets per day.

If you stop taking Okidol

You should stop taking this medication as soon as you feel better.

If you have any other doubts about the use of this medication, ask a doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medications, this medication can cause side effects, although not everyone will experience them.

Stop taking Okidol and seek medical attention immediatelyif at any time during treatment with Okidol you develop:

  • signs of intestinal bleeding such as: bright red stools, black tarry stools, vomiting blood or dark particles that look like coffee grounds
  • signs of skin rash, severe skin reactions, and blisters on the skin, mouth, and eyes
  • signs of a severe allergic reaction, such as:
    • unexplained difficulty breathing or wheezing
    • dizziness or faster heartbeats
    • swelling of your lips, face, throat, or tongue
  • worsening of Crohn's disease and colitis (a chronic inflammatory disease of the intestine with symptoms of abdominal pain, diarrhea, fever, and weight loss)

Inform your doctor if you experience:

  • fever, sore throat, mouth ulcers, headache, vomiting, unexplained bleeding, and severe fatigue
  • indigestion, stomach pain or abdominal pain, constipation, diarrhea, flatulence, or if you feel sick, chest pain, or irregular rapid heartbeats
  • kidney and liver problems associated with swelling in the arms and legs.

Side effects with Okidol may include:

Common(may affect up to 1 in 10 people)

  • indigestion (dyspepsia), nausea, abdominal pain, vomiting

Uncommon(may affect up to 1 in 100 people)

  • headache, dizziness, drowsiness
  • constipation, diarrhea, flatulence (gas), stomach lining inflammation
  • swelling due to fluid accumulation
  • itching and rashes
  • fatigue

Rare(may affect up to 1 in 1,000 people)

  • iron deficiency (anemia) caused by bleeding
  • tingling, numbness
  • blurred vision
  • ringing in the ear (tinnitus)
  • asthma
  • inflammation of the mouth lining
  • stomach ulcer
  • liver inflammation (hepatitis), increased liver enzymes, yellowing of the skin or the white part of the eyes (jaundice)
  • weight gain

Frequency not known(frequency cannot be estimated from available data)

  • change in blood cell count and platelets
  • allergic reactions (anaphylaxis)
  • adrenal gland damage
  • high blood pressure, hot flashes (vasodilation)
  • heart failure
  • kidney failure, kidney inflammation, abnormal kidney test results
  • colitis
  • worsening of gastrointestinal condition
  • dark or black stools
  • vomiting blood
  • stuffy and runny nose (rhinitis)
  • swelling of the throat
  • swelling of the deep layers of the skin, caused by excess fluid (e.g., face, hands)
  • difficulty breathing (dyspnea)
  • headache
  • breathing difficulty caused by narrowing of the airways
  • uncontrolled muscle contractions (convulsions)
  • sensitivity to sunlight or UV lamps
  • taste disturbances
  • mood changes
  • behavior changes
  • hair loss
  • itchy skin rash
  • stomach and/or intestinal bleeding, symptoms may include severe stomach pain, chills, nausea, vomiting, blood or dark particles that look like coffee grounds, heartburn, black tarry stools

Reporting side effects

If you experience any side effects, consult your doctor or pharmacist, even if they are possible side effects not listed in this package leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: www.notificaram.es.

By reporting side effects, you can help provide more information on the safety of this medication.

5. Storage of Okidol

Keep this medication out of sight and reach of children.

Keep it in the original package to protect it from light and moisture. This medication does not require any special storage temperature.

Do not use this medication after the expiration date shown on the package. The expiration date refers to the last day of the month indicated.

Medications should not be disposed of through wastewater or household waste. Deposit the packages and medications you no longer need at the SIGRE collection point in the pharmacy. If in doubt, ask your pharmacist how to dispose of packages and medications you no longer need. This will help protect the environment.

6. Packaging Content and Additional Information

Okidol Composition

  • The active ingredient is ketoprofen. Each tablet contains 25 mg of ketoprofen (as ketoprofen lysine salt).
  • The other components are: mannitol (E421), crospovidone, sodium lauryl sulfate, anhydrous colloidal silica (E551), sodium stearyl fumarate (E485), polyvinyl alcohol (E1203), macrogol 4000 (E1521), titanium dioxide (E171), talc (E553B), brilliant blue (E133), Quinoline Yellow aluminum lacquer (E104).

Product Appearance and Packaging Content

The Okidol film-coated tablets are round, blue, with a score line on one side.

The packages are available in 8, 10, 15, 16, or 20 tablets. Only some package sizes may be marketed.

Marketing Authorization Holder

Dompe farmaceutici S.P.A.

Via San Martino, 12

20122 – Milan

Italy

Manufacturer

Abiogen Pharma S.p.A.

Via Meucci, 36

56121 Ospedaletto

Pisa

Italy

This medicinal product is authorized in the EEA Member States under the following names:

Bulgaria Okitask 25 mg film-coated tablets

Croatia Okitask 25 mg film-coated tablets

France Okitask 25 mg film-coated tablets

Finland Okitask 25 mg film-coated tablets

Greece Okitask 25 mg film-coated tablets

Hungary Okitask 25 mg film-coated tablets

Latvia Okitask 25 mg film-coated tablets

Lithuania Okitask 25 mg film-coated tablets

Netherlands Okitask 25 mg film-coated tablets

Poland Okitask, 25 mg, film-coated tablets

Portugal Okiact 25 mg film-coated tablets

Romania Okitask 25 mg film-coated tablets

Slovenia Okitask 25 mg film-coated tablets

Spain Okidol 25 mg film-coated tablets

Date of the last revision of this leaflet: June 2023

Online doctors for OKIDOL 25 mg FILM-COATED TABLETS

Discuss questions about OKIDOL 25 mg FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for OKIDOL 25 mg FILM-COATED TABLETS?
OKIDOL 25 mg FILM-COATED TABLETS does not require a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in OKIDOL 25 mg FILM-COATED TABLETS?
The active ingredient in OKIDOL 25 mg FILM-COATED TABLETS is ketoprofen. This information helps identify medicines with the same composition but different brand names.
Who manufactures OKIDOL 25 mg FILM-COATED TABLETS?
OKIDOL 25 mg FILM-COATED TABLETS is manufactured by Dompe' Farmaceutici S.P.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of OKIDOL 25 mg FILM-COATED TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether OKIDOL 25 mg FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to OKIDOL 25 mg FILM-COATED TABLETS?
Other medicines with the same active substance (ketoprofen) include FASTUM 50 mg HARD CAPSULES, KETOPROFEN DOMPE 25 mg EFFERVSCENT TABLETS, OKIDOL 25 mg GRANULES. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media